Abstract
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study.
John A Eisman, Roberto Civitelli, Silvano Adami, Edward Czerwinski, Chris Recknor, Richard Prince, Jean-Yves Reginster, Mone Zaidi, Dieter Felsenberg, Claire Hughes, Nicole Mairon, Daiva Masanauskaite, David M Reid, Pierre D Delmas and Robert R Recker
The Journal of Rheumatology March 2008, 35 (3) 488-497;
John A Eisman
Roberto Civitelli
Silvano Adami
Edward Czerwinski
Chris Recknor
Richard Prince
Jean-Yves Reginster
Mone Zaidi
Dieter Felsenberg
Claire Hughes
Nicole Mairon
Daiva Masanauskaite
David M Reid
Pierre D Delmas
In this issue
The Journal of Rheumatology
Vol. 35, Issue 3
1 Mar 2008
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study.
John A Eisman, Roberto Civitelli, Silvano Adami, Edward Czerwinski, Chris Recknor, Richard Prince, Jean-Yves Reginster, Mone Zaidi, Dieter Felsenberg, Claire Hughes, Nicole Mairon, Daiva Masanauskaite, David M Reid, Pierre D Delmas, Robert R Recker
The Journal of Rheumatology Mar 2008, 35 (3) 488-497;
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study.
John A Eisman, Roberto Civitelli, Silvano Adami, Edward Czerwinski, Chris Recknor, Richard Prince, Jean-Yves Reginster, Mone Zaidi, Dieter Felsenberg, Claire Hughes, Nicole Mairon, Daiva Masanauskaite, David M Reid, Pierre D Delmas, Robert R Recker
The Journal of Rheumatology Mar 2008, 35 (3) 488-497;